Bovine Tuberculosis Diagnosis Market to Grow with a CAGR of 4.81% through 2028
The recognition of the significant economic, public
health, and animal welfare consequences associated with bTB. is expected to
drive the Global Bovine Tuberculosis Diagnosis Market growth in the forecast
period, 2024-2028.
According to TechSci Research report, “Bovine
Tuberculosis Diagnosis Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the Global Bovine
Tuberculosis Diagnosis Market stood at USD 735.27 million in 2022 and is
anticipated to grow with a CAGR of 4.81% in the forecast period, 2024-2028.
This can be attributed to the globalization of trade. The globalization of
livestock trade has amplified concerns about disease transmission across
borders. To facilitate international trade while safeguarding against bTB,
standardized and reliable diagnostic tools are increasingly in demand. This
trend reinforces the need for a robust global bTB diagnosis market.
Additionally, genomic epidemiology, which involves
sequencing the genomes of bTB strains, is gaining importance. This approach
allows for tracing the source of infection and understanding the transmission
dynamics of the disease. Genomic data can inform more targeted control
strategies.
The growth of the market is driven by several key
factors. These include the increasing cattle population, a growing demand for
animal products, heightened concerns regarding zoonotic diseases, strategic
initiatives undertaken by major companies, and supportive regulations and
government programs. As an example, the United States Department of
Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS)
initiated the National Tuberculosis Eradication Program in 1917 to eradicate
bovine TB in the U.S. This program involves regular and systematic testing of
cattle nationwide as part of a comprehensive surveillance program, among other
measures, and is expected to contribute to the market's expansion.
However, the COVID-19 pandemic had a negative impact
on the market, particularly in 2020. This decline can be attributed to the
closure and limited access to veterinary services due to lockdowns. Bovine TB
eradication programs in various countries faced significant challenges in
conducting diagnosis procedures during the pandemic. For instance, the Minister
for Environment, Energy, and Rural Affairs (MEERA) in the U.K. reported in
November 2021 that new eradication programs and related activities had been postponed
and delayed due to the sudden public health crisis, creating operational
obstacles.
Nevertheless, government agencies and key players took
various measures to continue their eradication programs during the pandemic.
For instance, the Department of Agriculture, Environment, and Rural Affairs
(DAERA) in the U.K. introduced measures in March 2020 to support the resumption
of bovine Tuberculosis (TB) testing activities that were disrupted during the
COVID-19 pandemic. These measures encouraged herd keepers to complete overdue
TB tests that had been delayed due to the pandemic. Similarly, the Michigan
Department of Agriculture and Rural Development (MDARD) in the U.S. ensured
that activities under the Bovine Tuberculosis Eradication Program, such as TB
testing, continued during the pandemic while adhering to precautions to prevent
the spread of the disease.
Several driving factors continue to fuel the market
for bovine TB diagnosis, including government-led bovine TB eradication and
surveillance initiatives, research and development efforts by major companies,
a return to normalcy post-pandemic, and the expansion of test types and service
offerings. For instance, in June 2019, the World Organization for Animal Health
(OIE) approved the Enferplex Bovine TB Antibody test, manufactured by Enfer
Group in Ireland. This test kit aids in detecting antibodies to M. bovis in
cattle serum samples and is recommended by OIE for serological infection
diagnosis and management. Enfer Group also expanded its distribution channel by
partnering with Sure Farm Ltd in the U.K., contributing to the market's growth
during the forecast period.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Bovine Tuberculosis Diagnosis Market.”
The Global Bovine Tuberculosis Diagnosis Market is
segmented into tests, regional distribution, and company.
Based on its tests, the traditional testing methods
had a dominant market presence and contributed significantly to revenue in
2022. Among these traditional tests, the Single Intradermal Comparative
Cervical Tuberculin (SICCT) test stands out as the most widely used clinical
examination technique worldwide for detecting bovine TB in different types of
herds and cattle. The Agriculture and Horticulture Development Board in the UK
even recommends SICCT as the primary screening test for TB in cattle. This test
involves injecting two types of tuberculin (bovine and avian) into the neck
skin layers of animals, with the results being read 72 hours after the
injection. The test's specificity and sensitivity at a standard interpretation
are exceptionally high at 99.98%, factors that instill trust and drive product
usage, thereby enhancing the growth of this market segment.
On the other hand, the molecular diagnostic tests
segment is expected to experience a CAGR in the bovine TB diagnosis market
during the forecast period. This growth is attributed to increased research and
development efforts by key industry players aimed at developing more advanced
and reliable molecular diagnostic products. These innovations include the
adoption of rapid and precise diagnostic tools like real-time PCR for
confirming bovine TB. For instance, in February 2020, Idvet introduced the ID
Gene Mycobacterium tuberculosis complex Duplex qPCR (product code IDTUB-50 and
IDTUB-100). This test kit comes with pre-prepared reagents, a positive control,
and an external internal control. It can be used to analyze lymph nodes and
peripheral tissue samples from cattle and various other livestock animals.
Based on region, Europe took the lead and captured a
significant share of revenue in 2022. The strong European presence can be
attributed to several factors, including the presence of major industry
players, the implementation of strategic initiatives aimed at expanding market
reach, government programs dedicated to eradicating bovine TB, and a
substantial cattle population. As per data from the European Commission, the
cattle population in the region exceeded 77 million as of December 2019.
Additionally, another significant driving force behind regional growth is the
relatively high prevalence of bovine tuberculosis in cattle herds. According to
the European Union Reference Laboratory, the disease's prevalence in Europe
increased from 1.0% to 1.8% between 2010 and 2019.
In the Asia Pacific region, the market is poised for
rapid growth, with a projected CAGR in the coming years. This growth can be
attributed to increasing awareness about the disease in developing nations and
the rising disposable income in key markets. The increasing demand for timely
and accurate diagnosis of bovine TB, particularly in countries like India, is
further fueling market expansion. According to a study published in the
Research Gate Journal in 2018, the estimated prevalence of bovine tuberculosis
in India ranged from 14.31% to 34.42%.
Major companies operating in Global Bovine
Tuberculosis Diagnosis Market are:
- IDEXX Laboratories Inc
- PBD Biotech Ltd
- Zoetis Inc
- Innovative Diagnostics
- Thermo Fisher Scientific Inc
- Enfer Group
- AsureQuality Australia Pty Ltd
- Bio-Rad Laboratories Inc
- BioNote Inc
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The Global Bovine Tuberculosis Diagnosis Market is
poised for transformation as emerging trends shape the landscape of bTB
diagnosis. Advances in molecular diagnostics, point-of-care testing,
serological assays, and the integration of AI and machine learning are expected
to drive innovation. Global collaboration and the use of genomic epidemiology
are changing the way bTB is monitored and managed,” said Mr. Karan Chechi,
Research Director with TechSci Research, a research-based management consulting
firm.
“Bovine Tuberculosis Diagnosis Market By
Tests (Molecular Diagnostic Tests, Serological
Tests, Traditional Tests), By Region, By
Competition Forecast & Opportunities, 2018-2028F”, has evaluated
the future growth potential of Global Bovine Tuberculosis Diagnosis Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Bovine Tuberculosis Diagnosis Market.
Contact
Mr. Ken Mathews
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +13322586602
Email: [email protected]
Website: www.techsciresearch.com